Over the past two decades, given the growing understanding of HP and evidence that HP is a modulator that can influence the occurrence and progression of GC, and alter the outcome of GC treatment, numerous studies have been conducted on the link between HP and GC. This evidence concerns the gene HP and gastric cancer.